Account
RAPP India bags digital mandate of Royal Canin
MUMBAI: RAPP India has bagged the India digital mandate of Royal Canin.
Royal Canin makes the most precise and effective nutrition for cats and dogs based on size, age, lifestyle, breed; to address specific needs with the aid of their vast knowledge about pets that only extensive research, scientific study and tireless dialogue with pet professionals, veterinarians and owners can provide.
With a worldwide outreach, the brand now plans to fortify its digital presence in India.
Royal Canin India marketing manager Rohan Kurian said, “At Royal Canin we are driven by a passion for cats and dogs. We wanted to share the science, research and education that go behind our products and services with pet owners as well to educate them on what is good for their pets. We were looking for a partner that would not only understand what we do and how we do it, but also why we do it. We are excited and are looking forward to our initiatives with RAPP India. With their new-age data driven approach it will be easier to start a meaningful and relevant dialogue with our consumers.”
RAPP India president Venkat Mallikarjunan added, “We are really proud to be associated with a leading global brand like Royal Canin. Our team is full of pet lovers and the prospect of enhancing the lives of dogs and cats with some of the most well researched and scientifically produced products in the world is very exciting. The category presents us the opportunity to explore innovative and creatively novel methods of building relationships with pet lovers using digital and other media.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
